4-Bromo-2-methanesulfonylbenzoic acid → HCID 58484757, compound
Reaction equation
[Br:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([OH:8])=O)=[C:4]([S:11]([CH3:14])(=[O:13])=[O:12])[CH:3]=1.[Cl:15][C:16]1[C:17]([N:23]2[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]2)=[N:18][CH:19]=[C:20]([Cl:22])[CH:21]=1>>[Br:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([N:26]2[CH2:27][CH2:28][N:23]([C:17]3[C:16]([Cl:15])=[CH:21][C:20]([Cl:22])=[CH:19][N:18]=3)[CH2:24][CH2:25]2)=[O:8])=[C:4]([S:11]([CH3:14])(=[O:13])=[O:12])[CH:3]=1Participants
3
Procedure
By reaction and treatment in the same manner as in Preparation Example 1 and using 4-bromo-2-methanesulfonylbenzoic acid (279 mg) and 1-(3,5-dichloropyridin-2-yl)piperazine (232 mg), the title compound (0.5 g) was obtained.
Workup
- customBy reaction and treatment in the same manner
- customas in Preparation Example 1
Sources & evidence
- ORD record
- ord-24272f9d214640c683b9531512f50741
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…